A research team at University College London discovered a 20 percent increase in Guillain-Barré syndrome cases among those who had taken the AstraZeneca COVID shot. New data suggests that AstraZeneca’s COVID-19 jab is associated with an increased risk of the degenerative nervous disorder Guillain-Barré syndrome (GBS), an autoimmune condition which can cause “devastating paralysis.” Researchers at University College London’s (UCL) Queen Square Institute of Neurology identified the Oxford/AstraZeneca-designed COVID jab as correlative with a rise in cases of GBS between two and four weeks of receiving the shot, the Telegraph reported.… Read the rest